Approval · Notice of Compliance 25359 · 2021
PMS-FINASTERIDE: Notice of Compliance 25359
Issued March 5, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25359
- Date
- March 5, 2021
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Revisions to the inner and outer labels
- Canadian reference product
- PROPECIAMERCK FROSST CANADA LTD
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-FINASTERIDE | Not yet assigned | — |
Medicinal ingredients
- FINASTERIDE 1 MG per TAB